An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma.
暂无分享,去创建一个
R. Ohno | A. Kuramoto | K. Okada | M. Ichimaru | T. Masaoka | K. Okada | Y. Sakai | M. Oguro | T. Arima | Y. Yoshida | H. Ariyoshi